Your browser doesn't support javascript.
loading
Systematic analysis of SCN5A variants associated with inherited cardiac diseases.
Hermida, Alexis; Jedraszak, Guillaume; Ader, Flavie; Denjoy, Isabelle; Fressart, Véronique; Maury, Phillipe; Beyls, Christophe; Bloch, Adrien; Clerici, Gaël; Daire, Elise; Defaye, Pascal; Dupin-Deguine, Delphine; Garçon, Loic; Klug, Didier; Ginglinger, Emmanuelle; Hermida, Jean-Sylvain; Jesel, Laurence; Khraiche, Diala; Kubala, Maciej; Lacotte, Jérôme; Laredo, Mikael; Leenhardt, Antoine; Le Guillou, Xavier; Lesaffre, Francois; Maltret, Alice; Magnin-Poull, Isabelle; Marijon, Eloi; Nambot, Sophie; Neyroud, Nathalie; Ninni, Sandro; Palmyre, Aurélien; Pasquie, Jean Luc; Proukhnitzky, Julie; Reant, Patricia; Richard, Pascale; Rollin, Anne; Rooryck, Caroline; Sacher, Frédéric; Schaefer, Elise; Vernier, Agathe; Winum, Pierre-François; Wahbi, Karim; Waintraub, Xavier; Waldmann, Victor; Weber, Sacha; Zouaghi, Amir; Charron, Philippe; Extramiana, Fabrice; Gandjbakhch, Estelle.
Affiliation
  • Hermida A; Cardiology, Arrhythmia, and Cardiac Stimulation Service, Amiens-Picardie University Hospital, Amiens, France; EA4666 HEMATIM, University of Picardie-Jules Verne, Amiens, France; Institute of Cardiology and ICAN Institute for Cardiometabolism and Nutrition, APHP, Pitié-Salpêtrière Hospital, Paris, Fr
  • Jedraszak G; EA4666 HEMATIM, University of Picardie-Jules Verne, Amiens, France; Molecular Genetics Laboratory, Amiens-Picardie University Hospital, Amiens, France.
  • Ader F; Unité Pédagogique de Biochimie, Département des Sciences Biologiques et Médicales, UFR de Pharmacie-Faculté de Santé, Paris, France; Unité Fonctionnelle de Cardiogénétique et Myogénétique Moléculaire et Cellulaire, DMU Biogem, Service de Biochimie Métabolique, AP-HP Sorbonne Université, Pitié-Salpêt
  • Denjoy I; Research Unit on Cardiovascular and Metabolic Diseases, Sorbonne Université, Inserm, UMRS-1166, Paris, France; CNMR Maladies Cardiaques Héréditaires Rares, APHP, Hôpital Bichat, Paris, France.
  • Fressart V; Unité Fonctionnelle de Cardiogénétique et Myogénétique Moléculaire et Cellulaire, DMU Biogem, Service de Biochimie Métabolique, AP-HP Sorbonne Université, Pitié-Salpêtrière-Charles Foix, Paris, France; Research Unit on Cardiovascular and Metabolic Diseases, Sorbonne Université, Inserm, UMRS-1166, Pa
  • Maury P; Service de Cardiologie, Centre hospitalier universitaire, Toulouse, France.
  • Beyls C; Cardiology, Arrhythmia, and Cardiac Stimulation Service, Amiens-Picardie University Hospital, Amiens, France.
  • Bloch A; Unité Pédagogique de Biochimie, Département des Sciences Biologiques et Médicales, UFR de Pharmacie-Faculté de Santé, Paris, France; Unité Fonctionnelle de Cardiogénétique et Myogénétique Moléculaire et Cellulaire, DMU Biogem, Service de Biochimie Métabolique, AP-HP Sorbonne Université, Pitié-Salpêt
  • Clerici G; Service de Cardiologie, Centre Hospitalier Universitaire, Saint Pierre, La Réunion, France.
  • Daire E; EA4666 HEMATIM, University of Picardie-Jules Verne, Amiens, France; Service de Pédiatrie, CHU Amiens, Amiens, France.
  • Defaye P; Service de Cardiologie, Centre Hospitalier Universitaire, Grenoble, France.
  • Dupin-Deguine D; Service de Génétique, CHU Toulouse, Toulouse, France.
  • Garçon L; EA4666 HEMATIM, University of Picardie-Jules Verne, Amiens, France; Molecular Genetics Laboratory, Amiens-Picardie University Hospital, Amiens, France.
  • Klug D; Service de Cardiologie, France CHU Lille, Inserm UMR1011, Institut Pasteur de Lille, Lille, France.
  • Ginglinger E; Service de Génétique, CH Mulhouse, Mulhouse, France.
  • Hermida JS; Cardiology, Arrhythmia, and Cardiac Stimulation Service, Amiens-Picardie University Hospital, Amiens, France.
  • Jesel L; Service de Cardiologie, CHU Strasbourg, Strasbourg, France.
  • Khraiche D; AP-HP, Pédiatrie, Hôpital Necker, Paris, France.
  • Kubala M; Cardiology, Arrhythmia, and Cardiac Stimulation Service, Amiens-Picardie University Hospital, Amiens, France.
  • Lacotte J; Service de Cardiologie, Institut Jacques Cartier, Massy, France.
  • Laredo M; Institute of Cardiology and ICAN Institute for Cardiometabolism and Nutrition, APHP, Pitié-Salpêtrière Hospital, Paris, France; Department of Genetics, Department of Cardiology, and Referral center for hereditary cardiac diseases, APHP, Pitié-Salpêtrière Hospital, Paris, France; Research Unit on Car
  • Leenhardt A; Research Unit on Cardiovascular and Metabolic Diseases, Sorbonne Université, Inserm, UMRS-1166, Paris, France; CNMR Maladies Cardiaques Héréditaires Rares, APHP, Hôpital Bichat, Paris, France.
  • Le Guillou X; Service de Génétique Médicale, CHU de Poitiers, Poitiers, France.
  • Lesaffre F; Service de Cardiologie, CHU Reims, Reims, France.
  • Maltret A; Service de Cardiopathie Congénitale, GHPSJ Hôpital Marie Lannelongue, Le Plessis Robinson, France.
  • Magnin-Poull I; Service de Cardiologie, CHU Nancy, Nancy, France.
  • Marijon E; Service de Cardiologie, Hôpital Européen Georges Pompidou, APHP, France; Université Paris Cité, INSERM, PARCC, Paris, France.
  • Nambot S; Centre de Référence Anomalies du Développement et Syndromes Malformatifs, FHU TRANSLAD, Hôpital d'Enfants, Dijon, France.
  • Neyroud N; Research Unit on Cardiovascular and Metabolic Diseases, Sorbonne Université, Inserm, UMRS-1166, Paris, France.
  • Ninni S; Service de Cardiologie, France CHU Lille, Inserm UMR1011, Institut Pasteur de Lille, Lille, France.
  • Palmyre A; Department of Genetics and Referral center for cardiac hereditary cardiac diseases, APHP, Ambroise Paré Hospital, Boulogne-Billancourt, France.
  • Pasquie JL; Service de Cardiologie, CHU Montpellier, Montpellier, France; PHYMEDEXP-CNRS UMR9214, Inserm U1046, Université de Montpellier et CHU de Montpellier, Montpellier, France.
  • Proukhnitzky J; Institute of Cardiology and ICAN Institute for Cardiometabolism and Nutrition, APHP, Pitié-Salpêtrière Hospital, Paris, France; Department of Genetics, Department of Cardiology, and Referral center for hereditary cardiac diseases, APHP, Pitié-Salpêtrière Hospital, Paris, France; Research Unit on Car
  • Reant P; Service de Cardiologie, LIRYC Institute, Bordeaux University Hospital, University of Bordeaux, Referral center for rare and inherited cardiomyopathies, Bordeaux, France.
  • Richard P; Unité Fonctionnelle de Cardiogénétique et Myogénétique Moléculaire et Cellulaire, DMU Biogem, Service de Biochimie Métabolique, AP-HP Sorbonne Université, Pitié-Salpêtrière-Charles Foix, Paris, France; Research Unit on Cardiovascular and Metabolic Diseases, Sorbonne Université, Inserm, UMRS-1166, Pa
  • Rollin A; Service de Cardiologie, Centre hospitalier universitaire, Toulouse, France.
  • Rooryck C; Service de Génétique Médicale, CHU Bordeaux, Bordeaux, France.
  • Sacher F; Service de Rythmologie, LIRYC Institute, Bordeaux University Hospital, CRMR Cardiogen, ERN Guard-Heart, INSERM 1045 University of Bordeaux, Bordeaux, France.
  • Schaefer E; Service de Génétique Médicale, Institut de Génétique Médicale d'Alsace, CHU Strasbourg, Strasbourg, France.
  • Vernier A; Victor Pauchet Clinic, Amiens, France.
  • Winum PF; Service de Cardiologie, CHU Nîmes, Nîmes, France.
  • Wahbi K; Service de Cardiologie, CHU Cochin, APHP, France.
  • Waintraub X; Institute of Cardiology and ICAN Institute for Cardiometabolism and Nutrition, APHP, Pitié-Salpêtrière Hospital, Paris, France; Department of Genetics, Department of Cardiology, and Referral center for hereditary cardiac diseases, APHP, Pitié-Salpêtrière Hospital, Paris, France.
  • Waldmann V; Service de Cardiologie, Hôpital Européen Georges Pompidou, APHP, France; Université Paris Cité, INSERM, PARCC, Paris, France.
  • Weber S; Service de Génétique, CHU Caen, Caen, France.
  • Zouaghi A; Service de Cardiologie, CH d'Antibes, Antibes, France.
  • Charron P; Department of Genetics, Department of Cardiology, and Referral center for hereditary cardiac diseases, APHP, Pitié-Salpêtrière Hospital, Paris, France; Research Unit on Cardiovascular and Metabolic Diseases, Sorbonne Université, Inserm, UMRS-1166, Paris, France; Department of Genetics and Referral c
  • Extramiana F; Research Unit on Cardiovascular and Metabolic Diseases, Sorbonne Université, Inserm, UMRS-1166, Paris, France; CNMR Maladies Cardiaques Héréditaires Rares, APHP, Hôpital Bichat, Paris, France; Université Paris Cité, Paris, France.
  • Gandjbakhch E; Institute of Cardiology and ICAN Institute for Cardiometabolism and Nutrition, APHP, Pitié-Salpêtrière Hospital, Paris, France; Department of Genetics, Department of Cardiology, and Referral center for hereditary cardiac diseases, APHP, Pitié-Salpêtrière Hospital, Paris, France; Research Unit on Car
Heart Rhythm ; 2024 Aug 10.
Article de En | MEDLINE | ID: mdl-39134129
ABSTRACT

BACKGROUND:

SCN5A variants are associated with a spectrum of cardiac electrical disorders with clear phenotypes. However, they may also be associated with complex phenotypic traits like overlap syndromes or pleiotropy, which have not been systematically described. In addition, the involvement of SCN5A in dilated cardiomyopathies (DCMs) remains controversial.

OBJECTIVE:

We aimed to evaluate the different phenotypes associated with pathogenic (P)/likely pathogenic (LP) SCN5A variants and to determine the prevalence of pleiotropy in a large multicentric cohort of P/LP SCN5A variant carriers.

METHODS:

The DNA of 13,510 consecutive probands (9960 with cardiomyopathies) was sequenced with a custom panel of genes. Individuals carrying a heterozygous single P/LP SCN5A variant were selected and phenotyped.

RESULTS:

The study included 170 P/LP variants found in 495 patients. Of them, 119 (70%) were exclusively associated with a single well-established phenotype 91 with Brugada syndrome, 15 with type 3 long QT syndrome, 6 with progressive cardiac conduction disease, 4 with multifocal ectopic Purkinje-related premature contractions, and 3 with sick sinus syndrome. Thirty-two variants (19%) were associated with overlap syndromes or pleiotropy. The 19 remaining variants (11%) were associated with atypical or unclear phenotypes. Of those, 8 were carried by 8 patients presenting with DCM with a debatable causative genotype/phenotype link.

CONCLUSION:

Most P/LP SCN5A variants were found in patients with primary electrical disorders, mainly Brugada syndrome. Nearly 20% were associated with overlap syndromes or pleiotropy, underscoring the need for comprehensive phenotypic evaluation. The concept of SCN5A variants causing DCM is extremely rare (8/9960) if not questionable.
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Heart Rhythm Année: 2024 Type de document: Article Pays d'affiliation: France Pays de publication: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Heart Rhythm Année: 2024 Type de document: Article Pays d'affiliation: France Pays de publication: États-Unis d'Amérique